CCG-100602
CCG-100602 inhibits RhoA/C-mediated, SRF-driven luciferase expression in PC-3 prostate cancer cells (IC50 :9.8 µM) .
Product Specifications
CAS Number
1207113-88-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
478.82
Molecular Formula
C21H17ClF6N2O2
Notes
Research use only, not for human use.
Receptor
Rho
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP77227_P050 100 µL
RHBDD3 Antibody - C-terminal region (ARP77227_P050)
Sign In for Pricing
View Details 